BALLARD PARTNERS

Lobbying for ALKERMES, INC. · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · $140,000.00 income · posted Jan 12, 2026

Lobbying activity 1

Health Issues

Provide guidance and advice regarding mental health, public health and regulatory reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem